Viatris Inc. VTRS

17.83 0.41 2.35% as of 25 Sep
Market cap
$20.0B
P/E
0.0×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Viatris Inc. (VTRS) Operating margin

Viatris Inc.'s operating margin over the twelve months to 30 June 2026 was −0.59%, up 18.0 percentage points from fiscal 2025 (−18.6%). Over the past ten years it has ranged from −18.6% (fiscal 2025) to 15.5% (fiscal 2015) — the current reading is the lowest in ten years. That is below the Drug Manufacturers Specialty & Generic industry median of 0.00% and below the Healthcare sector median of 0.00%.

Operating margin, annual

Annual

Period Operating margin Change (points)
FY2025 −18.6% (18.69)
FY2024 0.07% (4.90)
FY2023 4.97% (4.96)
FY2022 9.93% 10.12
FY2021 −0.19% 1.57
FY2020 −1.76% (7.98)
FY2019 6.22% (1.70)
FY2018 7.92% (4.15)
FY2017 12.1% 5.76
FY2016 6.31% (9.18)

Quarterly

Period Operating margin Change (points)
Jun 2026 0.17% 2.44
Mar 2026 −2.27% 2.93
Dec 2025 −5.20% (9.96)
Sep 2025 4.76% (1.74)
42 more quarters

Against its own ten years

Low −18.6% High 15.5%
Ten-year median 6.22%
Current reading's percentile 9

Operating margin against peers

Company Operating margin
UTHR United Therapeutics Corporation compare 44.4%
ZTS Zoetis Inc. compare 37.1%
NBIX Neurocrine Biosciences, Inc. compare 23.6%
HLN Haleon PLC Sponsored ADR compare 17.9%
RDY Dr. Reddy's Laboratories Ltd compare 10.9%
TEVA Teva Pharmaceutical Industries Ltd. compare 8.77%
ELAN Elanco Animal Health Incorporated compare 1.61%
VTRS Viatris Inc. −0.59%
HIMS Hims & Hers Health, Inc. compare −5.99%
Drug Manufacturers Specialty & Generic industry median 0.00%
Healthcare sector median 0.00%
Market median 0.00%

What Operating margin is

EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.

EBIT ÷ Revenue

The full definition of Operating margin →

More on VTRS